#Insertable Cardiac Monitors (ICM) Market Demand
Explore tagged Tumblr posts
Text
Insertable Cardiac Monitors (ICM) Market Trends, Opportunities and Forecast By 2028
The Insertable Cardiac Monitors (ICM) Market sector is undergoing rapid transformation, with significant growth and innovations expected by 2028. In-depth market research offers a thorough analysis of market size, share, and emerging trends, providing essential insights into its expansion potential. The report explores market segmentation and definitions, emphasizing key components and growth drivers. Through the use of SWOT and PESTEL analyses, it evaluates the sector’s strengths, weaknesses, opportunities, and threats, while considering political, economic, social, technological, environmental, and legal influences. Expert evaluations of competitor strategies and recent developments shed light on geographical trends and forecast the market’s future direction, creating a solid framework for strategic planning and investment decisions.
Brief Overview of the Insertable Cardiac Monitors (ICM) Market:
The global Insertable Cardiac Monitors (ICM) Market is expected to experience substantial growth between 2024 and 2031. Starting from a steady growth rate in 2023, the market is anticipated to accelerate due to increasing strategic initiatives by key market players throughout the forecast period.
Get a Sample PDF of Report - https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-insertable-cardiac-monitors-icm-market
Which are the top companies operating in the Insertable Cardiac Monitors (ICM) Market?
The report profiles noticeable organizations working in the water purifier showcase and the triumphant methodologies received by them. It likewise reveals insights about the share held by each organization and their contribution to the market's extension. This Global Insertable Cardiac Monitors (ICM) Market report provides the information of the Top Companies in Insertable Cardiac Monitors (ICM) Market in the market their business strategy, financial situation etc.
Abbott, Medtronic, BioTelemetry, Inc., Siemens, Boston Scientific Corporation, Koninklijke Philips N.V, Shenzhen Mindray Bio-Medical Electronics Co., Ltd, SHL Telemedicine, The ScottCare Corporation, Medicomp Inc., Preventice Solutions, Inc.
Report Scope and Market Segmentation
Which are the driving factors of the Insertable Cardiac Monitors (ICM) Market?
The driving factors of the Insertable Cardiac Monitors (ICM) Market are multifaceted and crucial for its growth and development. Technological advancements play a significant role by enhancing product efficiency, reducing costs, and introducing innovative features that cater to evolving consumer demands. Rising consumer interest and demand for keyword-related products and services further fuel market expansion. Favorable economic conditions, including increased disposable incomes, enable higher consumer spending, which benefits the market. Supportive regulatory environments, with policies that provide incentives and subsidies, also encourage growth, while globalization opens new opportunities by expanding market reach and international trade.
Insertable Cardiac Monitors (ICM) Market - Competitive and Segmentation Analysis:
**Segments**
- By Product Type: Subcutaneous ICM, Transvenous ICM - By Technology: Electrocardiogram (ECG), Optical Fiber, Others - By Indication: Atrial Fibrillation, Bradycardia, Tachycardia, Others - By End-User: Hospitals, Cardiac Clinics, Ambulatory Surgical Centers, Others
The global insertable cardiac monitors (ICM) market is expected to witness significant growth from 2021 to 2028. The increasing prevalence of cardiovascular diseases, coupled with advancements in healthcare technology, is driving the demand for insertable cardiac monitors globally. The market is segmented by product type into subcutaneous ICM and transvenous ICM. Subcutaneous ICMs are non-invasive devices that are implanted just beneath the skin to monitor heart activity, while transvenous ICMs are inserted into the chest wall to monitor heart rhythms more closely. Based on technology, the market is categorized into electrocardiogram (ECG), optical fiber, and others. The ECG segment dominates the market due to its wide usage and effectiveness in detecting cardiac abnormalities. Moreover, the indications for ICMs include atrial fibrillation, bradycardia, tachycardia, among others, with atrial fibrillation holding a significant share owing to its high prevalence globally. Hospitals, cardiac clinics, ambulatory surgical centers, and others are the key end-users of insertable cardiac monitors.
**Market Players**
- Medtronic - Abbott - Biotronik - Boston Scientific Corporation - LivaNova PLC - BIOTRICITY INC. - Medtronic - Koninklijke Philips N.V. - Preventice Solutions, Inc. - Hill-Rom Services Inc.
Leading market players in the global insertable cardiac monitors (ICM) industry are focusing on research and development initiatives to introduce innovative products and strengthen their market presence.The global insertable cardiac monitors (ICM) market is highly competitive, with key players such as Medtronic, Abbott, Biotronik, Boston Scientific Corporation, and LivaNova PLC leading the industry. These companies have a strong focus on research and development to introduce innovative products that cater to the evolving needs of healthcare providers and patients. For instance, Medtronic has been actively involved in developing advanced monitoring solutions to improve the diagnosis and management of cardiac conditions. Abbott, on the other hand, has been instrumental in introducing cutting-edge technologies in the field of cardiac monitoring, enhancing patient outcomes and streamlining healthcare delivery.
In addition to established players, emerging companies like BIOTRICITY INC., Koninklijke Philips N.V., Preventice Solutions, Inc., and Hill-Rom Services Inc. are also making a mark in the insertable cardiac monitor market. These companies are investing in technological advancements to offer novel solutions that address unmet needs in cardiac care. BIOTRICITY INC., for instance, focuses on developing remote monitoring solutions that provide real-time data to healthcare providers, enabling timely interventions and improved patient outcomes. Koninklijke Philips N.V. is known for its expertise in digital health solutions, integrating data analytics and artificial intelligence to enhance diagnostic capabilities in cardiac monitoring.
The market players in the insertable cardiac monitor segment are strategically collaborating with healthcare institutions, research organizations, and regulatory bodies to ensure the successful development and commercialization of their products. By leveraging partnerships and alliances, these companies can access new markets, gain regulatory approvals, and foster innovation in cardiac monitoring technologies. Moreover, mergers and acquisitions are prevalent in the industry as companies look to expand their product portfolios, diversify their customer base, and strengthen their competitive position in the market.
In terms of market dynamics, the growing prevalence of cardiovascular diseases, particularly atrial fibrillation, is a key driver for the insertable cardiac monitor market. As the aging population increases and lifestyle factors contribute to heart-related conditions, the demand for**Market Players**
Abbott, Medtronic, BioTelemetry, Inc., Siemens, Boston Scientific Corporation, Koninklijke Philips N.V, Shenzhen Mindray Bio-Medical Electronics Co., Ltd, SHL Telemedicine, The ScottCare Corporation, Medicomp Inc., Preventice Solutions, Inc.
The global insertable cardiac monitor market is witnessing significant growth due to the rising prevalence of cardiovascular diseases and technological advancements in healthcare. The market is segmented by product type, technology, indication, and end-user, providing a comprehensive overview of the industry landscape. Subcutaneous ICMs and transvenous ICMs offer unique monitoring capabilities, with ECG technology being the dominant choice for cardiac monitoring. Atrial fibrillation, bradycardia, and tachycardia are among the key indications for ICMs, with atrial fibrillation driving a substantial share of the market. Hospitals, cardiac clinics, and ambulatory surgical centers serve as primary end-users for insertable cardiac monitors.
Leading market players such as Medtronic, Abbott, and Boston Scientific Corporation are at the forefront of innovation in the ICM industry. These companies invest heavily in research and development to introduce cutting-edge products that cater to the evolving needs of healthcare providers and patients. Collaborations with healthcare institutions and regulatory bodies are crucial for product development and market expansion. Emerging players like Preventice Solutions, Inc. and Koninklijke Philips N.V. are also making significant strides in the market by focusing
North America, particularly the United States, will continue to exert significant influence that cannot be overlooked. Any shifts in the United States could impact the development trajectory of the Insertable Cardiac Monitors (ICM) Market. The North American market is poised for substantial growth over the forecast period. The region benefits from widespread adoption of advanced technologies and the presence of major industry players, creating abundant growth opportunities.
Similarly, Europe plays a crucial role in the global Insertable Cardiac Monitors (ICM) Market, expected to exhibit impressive growth in CAGR from 2024 to 2028.
Explore Further Details about This Research Insertable Cardiac Monitors (ICM) Market Report https://www.databridgemarketresearch.com/reports/global-insertable-cardiac-monitors-icm-market
Key Benefits for Industry Participants and Stakeholders: –
Industry drivers, trends, restraints, and opportunities are covered in the study.
Neutral perspective on the Insertable Cardiac Monitors (ICM) Market scenario
Recent industry growth and new developments
Competitive landscape and strategies of key companies
The Historical, current, and estimated Insertable Cardiac Monitors (ICM) Market size in terms of value and size
In-depth, comprehensive analysis and forecasting of the Insertable Cardiac Monitors (ICM) Market
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2024-2031) of the following regions are covered in Chapters
The countries covered in the Insertable Cardiac Monitors (ICM) Market report are U.S., Canada and Mexico in North America, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA
Detailed TOC of Insertable Cardiac Monitors (ICM) Market Insights and Forecast to 2028
Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Research Methodology
Part 04: Insertable Cardiac Monitors (ICM) Market Landscape
Part 05: Pipeline Analysis
Part 06: Insertable Cardiac Monitors (ICM) Market Sizing
Part 07: Five Forces Analysis
Part 08: Insertable Cardiac Monitors (ICM) Market Segmentation
Part 09: Customer Landscape
Part 10: Regional Landscape
Part 11: Decision Framework
Part 12: Drivers And Challenges
Part 13: Insertable Cardiac Monitors (ICM) Market Trends
Part 14: Vendor Landscape
Part 15: Vendor Analysis
Part 16: Appendix
Browse More Reports:
Japan: https://www.databridgemarketresearch.com/jp/reports/global-insertable-cardiac-monitors-icm-market
China: https://www.databridgemarketresearch.com/zh/reports/global-insertable-cardiac-monitors-icm-market
Arabic: https://www.databridgemarketresearch.com/ar/reports/global-insertable-cardiac-monitors-icm-market
Portuguese: https://www.databridgemarketresearch.com/pt/reports/global-insertable-cardiac-monitors-icm-market
German: https://www.databridgemarketresearch.com/de/reports/global-insertable-cardiac-monitors-icm-market
French: https://www.databridgemarketresearch.com/fr/reports/global-insertable-cardiac-monitors-icm-market
Spanish: https://www.databridgemarketresearch.com/es/reports/global-insertable-cardiac-monitors-icm-market
Korean: https://www.databridgemarketresearch.com/ko/reports/global-insertable-cardiac-monitors-icm-market
Russian: https://www.databridgemarketresearch.com/ru/reports/global-insertable-cardiac-monitors-icm-market
Data Bridge Market Research:
Today's trends are a great way to predict future events!
Data Bridge Market Research is a market research and consulting company that stands out for its innovative and distinctive approach, as well as its unmatched resilience and integrated methods. We are dedicated to identifying the best market opportunities, and providing insightful information that will help your business thrive in the marketplace. Data Bridge offers tailored solutions to complex business challenges. This facilitates a smooth decision-making process. Data Bridge was founded in Pune in 2015. It is the product of deep wisdom and experience.
Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC: +653 1251 1985
Email:- [email protected]
#Insertable Cardiac Monitors (ICM) Market Size#Insertable Cardiac Monitors (ICM) Market Shares#Insertable Cardiac Monitors (ICM) Market Forecast#Insertable Cardiac Monitors (ICM) Market Growth#Insertable Cardiac Monitors (ICM) Market Demand
0 notes
Text
Implantable Cardiac Monitor Market Overview and Forecast Analysis up to 2026
Transparency Market Research (TMR) has published a new report titled ‘Implantable Cardiac Monitor Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ According to the report, the global implantable cardiac monitor market was valued at US$ 679.24 Mn in 2017. The market is anticipated to reach US$ 1,464.26 Mn by 2026, expanding at a CAGR of 8.7% during the forecast period. Rise in the incidence of cardiac arrhythmia and increase in geriatric population are expected to augment the global market from 2018 to 2026. The global implantable cardiac monitor market is projected to expand, owing to prolonged ECG monitoring function, acceptance of and rise in demand for subcutaneous insertible cardiac devices, and increase in technological advancements.
Read Report Overview: https://www.transparencymarketresearch.com/implantable-cardiac-monitors-market.html
Rise in Prevalence of Cardiac Arrhythmia is Propelling the Global Cardiac Monitor Market
The global implantable cardiac monitor market is expanding at a high growth rate, driven by an increase in prevalence of cardiac arrhythmia. As per research, about 14 million people are suffering from some forms of cardiac arrhythmia in the U.S. with more than 4 million Americans have recurrent arrhythmia and 5 million Americans are currently living with heart conditions. In Asia Pacific, Japan is expected to reach 1 million cardiac arrhythmia patients in the coming years.
Request a PDF Sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=50316
Increase in the Global Geriatric Population is Driving the Need for Effective Treatment, Globally
Prevalence of cardiovascular diseases such as heart stroke and improper function of the heart are driving the need for cardiac monitoring devices in order to monitor irregular heart rhythms. Elderly people are often prone to cardiac arrhythmia, especially atrial fibrillation, which occurs in old age, resulting in need for cardiac monitors. External cardiac monitors are not feasible for old people to wear or carry on a day to day basis. This has led to an increase in the adoption of insertable cardiac monitors. Implantable cardiac monitor devices offer better ECG monitoring service and also last for three years. Rise in the geriatric population demands better treatment options, which in turn, is likely to provide opportunities for companies operating in the global implantable cardiac monitor market.
Enquiry before Buying Implantable Cardiac Monitor Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=50316
North America Dominates the Global Implantable Cardiac Market Owing to Rise in Demand for Implantable Cardiac Monitors
North America dominates the global implantable cardiac monitor market, owing to the approval of cardiac monitors and the presence of major players in this region. Implantable cardiac monitors are niche, and this offers significant opportunities for companies to expand and invest in the region. Also, a rise in the prevalence of cardiovascular conditions that need further monitoring contributes to the demand for implantable cardiac monitors. Rise in atrial fibrillation, a type of cardiac arrhythmia, and other arrhythmias drives the market in the region.
A subcutaneous cardiac monitor is a new innovation that is gaining trust and popularity among the geriatric population, owing to its prolonged ECG monitoring benefits. Therefore, easy adoption of ICM is fuelling the market in the region.
Request For Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=50316
First and only Smartphone Compatibility Implantable Medical Device for Cardiac Monitoring and Rise in Investments in Research & Development Offer Significant Opportunities to New Entrants
Key market players have invested in establishing a better way for the treatment of patients by providing innovate ways of monitoring irregular heart rhythms on smartphones. This innovation allows physicians to directly access data and keep track of patients’ condition.
Also, companies are readily investing in this type of technology. They also hold a strong portfolio of products in the pipeline that are ready to enter the market. Due to the presence of few players in the global market, other companies have a significant opportunity to enter the market with innovative solutions.
Buy now Implantable Cardiac Monitor Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=50316<ype=S
Investments and Mergers & Acquisitions by Key Players are Driving the Implantable Cardiac Monitor Market
Key players dominating the global implantable cardiac monitor markets are Medtronic, Abbott, Biotronik, Angel Medical Systems, Inc., vectoriousmedtech.com, Boston Scientific Corporation or its affiliates, and Biosense Webster, Inc.. Major players are focusing on mergers and acquisitions and are incorporating innovative technologies to expand their footprint in the global implantable cardiac monitor market.
More Trending Reports by Transparency Market Research:
https://www.prnewswire.com/news-releases/growing-uptake-in-cancer-diagnostics-and-therapeutics-open-new-frontiers-in-radiopharmaceutical-market-valuation-predicted-to-touch-us-5-4-bn-by-2027--tmr-301268782.html
https://www.prnewswire.com/news-releases/intravascular-ultrasound-ivus-devices-market-gains-from-rise-in-diagnosis-of-complex-cto-lesions-finds-tmr-301361488.html
https://www.prnewswire.co.uk/news-releases/sizeable-numbers-to-endorse-benefits-and-efficacy-of-umbrella-of-hormone-replacement-therapies-underscores-growth-in-testosterone-replacement-therapy-market-valuation-projected-to-touch-us-2-2-bn-by-2027-says-tmr-819153496.html
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
0 notes
Text
Electrophysiology Devices Market Expected To Have An estimated Worth Of $12.2 Billion Valuation By 2026
The global electrophysiology devices market size is expected to reach USD 12.2 billion by 2026, according to a new report by Grand View Research, Inc. expanding at a CAGR of 11.70% over the forecast period. The demand for electrophysiology devices is expected to increase owing to growing old age population and frequent cardiac arrhythmias incidents. Adoption of ablation and diagnostics techniques among physicians has resulted in increased usage of the product in the past few years and is likely to drive market growth. Development of new devices such as Nanostim-dual-chamber leadless pacemaker is also anticipated to fuel demand in the market.
Cardiac ablation has gained popularity as the first-line treatment, rendering a 95% success rate for several rhythm disorders and is anticipated to be a key driving factor for growth. Diagnostic electrophysiology catheters are estimated to grow at high CAGR in the foreseeable future. Technological developments such as laser ablation, cryo-ablation, and ultrasound ablation, coupled with optimized mapping techniques are anticipated to augment market growth over the forecast period.
To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/electrophysiology-devices-market
Further Key Findings from the Study Suggest:
Electrophysiology diagnostic devices held a major share in the application segment in 2018. Collectively, cardiac monitors held the largest market share in electrophysiology diagnostic segment. The devices include Holter monitors, ECG monitors, and Insertable Cardiac Monitors (ICM). Growth can be attributed to increasing usage of digital and portable systems in the ambulatory setting and improving diagnostic interventional capabilities of healthcare consultants.
EP mapping and imaging systems are anticipated to grow rapidly during the forecast period. Technological improvements such as Optima IGS 320 and GE Healthcare’s Innova IGS 520 are projected to provide future opportunities for growth. These are dose efficient products and cardiac imaging systems that allow interventional cardiologist to perform compound interventional procedures with accuracy and ease.
Electrophysiology treatment devices include pacemakers, implantable cardioverter defibrillators (ICD) and catheters. Pacemakers emerged as the largest treatment devices segment in 2018 owing to rising prevalence of different types of arrhythmia among the population and extensive usage of cardiac rhythm management devices. However, rising costs related to the product, existence of strict regulations and accessibility of substitute therapies are anticipated to hamper the growth. Automated external defibrillators (AEDs) are expected to witness high growth rate during the forecast period attributed to increasing use in treating out-of-hospital cases of cardiac arrest.
North America held the largest market share in 2018 owing to a high patient base of cardiac arrhythmia resulting from unhealthy lifestyle habits. Increasing demand for the latest healthcare infrastructure and rising consumer awareness are anticipated to propel growth.
Asia-Pacific is a lucrative market owing to the high rate of unmet medical requirements leading to an increase in the number of patients. Rapid developments in healthcare infrastructure and increase in disposable income in emerging economies such as India and China are expected to provide new avenues and opportunities for companies to capitalize over the forecast period.
There are top 4 players who command around 60% of the electrophysiology devices market. Boston Scientific Corporation, Medtronic Plc., Abbot Laboratories, and Biosense Webster, Inc., is predominantly led by powerful product portfolios and significant brand recognition. Other players include Biotronik SE & Co. KG.
Grand View Research has segmented the global electrophysiology devices market based on medical condition, service and region:
Electrophysiology Devices Application Outlook (Revenue, USD Million; 2015 - 2026)
Treatment Devices
Diagnostic Devices
Implantable Cardioverter Defibrillators (ICDs)
Automated external defibrillators (AEDs)
Pacemakers
CRT-P
CRT-D
Catheters
Others
Holter Monitoring Devices
Diagnostic Electrophysiology Catheters
Electrocardiograph (ECG)
EP Mapping & Imaging Systems
Implantable cardiac monitors (ICM)
Others
Electrophysiology Devices Indication Outlook (Revenue, USD Million; 2015 - 2026)
Atrial Fibrillation (AF)
Supraventricular Tachycardia
Atrioventricular Nodal Re-entry Tachycardia (AVNRT)
Wolff-Parkinson-White Syndrome (WPW)
Bradycardia
Others
Electrophysiology Devices End-Use Outlook (Revenue, USD Million; 2015 - 2026)
Hospitals
Ambulatory Surgical Centers
Others
Electrophysiology Devices Region Outlook (Revenue, USD Million; 2015 - 2026)
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
U.S.
Canada
UK
Germany
France
Italy
Spain
Japan
China
India
Australia
Brazil
Mexico
Saudi Arabia
South Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
0 notes
Text
Remote Cardiac Monitoring Services Market , Business Scenario Analysis By Global Industry Trend, Share, Sales Revenue, Growth Rate and Opportunity Assessment till 2026
Reports and Data has recently published a new research report on Global Remote Cardiac Monitoring Services Market that covers current development scenario and emerging trends of the market. The research report provides a comprehensive assessment of the market size, market share, revenue growth, and provides a futuristic perspective about the market trends, growth factors, facts, and industry validated market data. The report applies advanced statistical tools such as Porter’s Five Forces analysis and SWOT analysis to shed light on the competitive landscape of the global Remote Cardiac Monitoring Services market. The report covers all the critical and essential information relating to the global Remote Cardiac Monitoring Services market which helps the readers and clients gain a thorough understanding of the market.
To know more about the report @ https://www.reportsanddata.com/report-detail/remote-cardiac-monitoring-services-market
The report provides an in-depth analysis of the key developments and innovations of the market such as research and development advancements, product launches, mergers & acquisitions, joint ventures, partnerships, government deals, and collaborations. The report offers a comprehensive assessment of key players in the market along with their global position, financial standing, business expansion plans, production and manufacturing capacity, and strategic alliances.
Key players in the market include
Preventice Solutions, Honeywell Life Care Solutions, Cardionet, Koninklijke Philips, Medtronic, Boston Scientific Corporation, Biotronik SE & Co. KG, Cardiac Science Corporation, Hill-Rom Holdings, Inc., LivaNova PLC, ReliantHeart Inc., St. Jude Medical, Inc, and Schiller AG.
For a better understanding of the global Remote Cardiac Monitoring Services market dynamics, a regional analysis of the market across key geographical areas is offered in the report. The market is spread across key geographical regions such as North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Each region is analysed on the basis of the market scenario in the major countries of the regions to provide a deeper understanding of the market. It provides insights into production and consumption patterns, supply and demand ratio, export/import, current and emerging trends and demands, market share, market size, revenue contribution, and presence of key players in each region.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1444
In-depth regional analysis includes:
· North America (U.S., Canada, Mexico)
· Europe (Italy, U.K., Germany, France, Rest of EU)
· Asia Pacific (India, China, Japan, South Korea, Australia, Rest of APAC)
· Latin America (Chile, Brazil, Argentina, Peru, Rest of Latin America)
· Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Furthermore, the report segments Remote Cardiac Monitoring Services market on the basis of key product types and applications and provides details about the revenue growth, revenue CAGR, and revenue share each segment is expected to register over the forecast period.
Product Type Outlook (Revenue, USD Billion; 2016-2026)
Cardiac Event Recorder
Loop memory Monitor
Symptom event monitor
Holter Monitor
Insertable Cardiac Monitor (ICM)
Mobile Cardiac Telemetry Devices
Technology Type Outlook (Revenue, USD Billion; 2016-2026)
Digital Health Technology
Mobile Cardiac Telemetry Monitoring (MCT/MCOT)
Artificial Intelligence
AutoDetect Monitors
Manual Event Monitor
Smart Wearable ECG Monitors
Event monitoring Type Outlook (Revenue, USD Billion; 2016-2026)
Pre-Symptom (Memory Loop)
Post-Symptom Event Monitor
Application Type Outlook (Revenue, USD Billion; 2016-2026)
Coronary Artery Disease
Arrhythmia
Hypertension
End-user Outlook (Revenue, USD Billion; 2016-2026)
Diagnostic Centers
Hospitals
Ambulatory Surgical Centers
Academic and Research Institutions
R&D Centers
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1444
Key Features of the Global Remote Cardiac Monitoring Services Market Report:
· Comprehensive analysis of the key players operating in the market along with their SWOT analysis, their business profiles, business overview, market share, global position, and market value
· Identification and analysis of significant trends and factors driving revenue growth of the market
· Analysis of the competitive landscape along with strategic mergers, expansions, agreements, partnerships, joint ventures, acquisitions, and product launches
· Assessment of each market segment along with their growth trends and market revenue contribution
· Study of the key regions to pinpoint growth potential and study opportunities, threats, limitations, and risks
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1444
Thank you for reading our report. Please get in touch with us to know more about the report and customization of the report. Our team will ensure the report is tailored to meet your requirements.
0 notes
Text
Insertable Cardiac Monitors (ICM) Market to Witness Massive CAGR Growth of 8.9% with Innovative Technology | Key Competitors Are Abbott, Medtronic, BioTelemetry, Inc., Siemens, Boston Scientific Corporation
The Insertable Cardiac Monitors (ICM) Market research report delivers a thorough analysis of this business sphere with expert insights on the past and present growth matrix. Factors such as driving forces, opportunities, and obstacles that will shape the industry dynamics are explained in detail. Besides, the study meticulously defines the size and shares of the market and its segments, uncovering the key growth prospects in the process. Global insertable cardiac monitors (ICM) market is set to witness a substantial CAGR of 8.9% in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. This rise in market value can be attributed to increasing demand for insertable cardiac monitors.
This qualitative and quantitative analysis will contain key product offerings, crucial differentiators, revenue share, market size, market status, and strategies of top leading players. The report will additionally cover key agreements, associations, and global partnerships soon to change the dynamics of the market on a global scale.
Get Sample Report + All Related Graphs & Charts @ https://www.databridgemarketresearch.com/reports/global-insertable-cardiac-monitors-icm-market
Segmentation: Global Insertable Cardiac Monitors (ICM) Market
By Type
Multiple Lead Mobile Cardiac Telemetry Systems
Mobile Cardiac Telemetry Patch
Others
By Disease
Renal Disease
Cardiac Arrhythmias
Atrial Fibrillation
Stroke
Syncope
Others
The market research report provides thorough insights that are enhancing the growth of the global Insertable Cardiac Monitors (ICM) Market, along with this, the report also provides the available opportunities and current trends that are influencing the growth of the Insertable Cardiac Monitors (ICM) Market and are widely used by the manufacturers. Moreover, the market research report study provides the information on current market development, its drivers, restrains and changing technologies and investment structure of the global Insertable Cardiac Monitors (ICM) Market. Along with this, the research report also elaborates market tendencies, development scope, future opportunities and the maturity analysis of the Insertable Cardiac Monitors (ICM) Market.
Major Key players profiled in the report include: Abbott, Medtronic, BioTelemetry, Inc., Siemens, Boston Scientific Corporation, Koninklijke Philips N.V.
The report is specially designed to analyse and discuss the latest developments in the Global Insertable Cardiac Monitors (ICM) Market. The study’s objective includes:
Presenting the current products being sold regionally.
Looking at technology in the market and in terms of development.
Tracing out the improvements that companies are engineering and where these improvements may load within the market.
Studying how close the industry is responding to the new products in the Global Insertable Cardiac Monitors (ICM) Market.
Some of the key questions answered in this report:
What will the market growth rate, growth momentum or acceleration market carries during the forecast period?
Which are the key factors driving the Insertable Cardiac Monitors (ICM) market?
What was the size of the emerging Insertable Cardiac Monitors (ICM) market by value in 2020?
What will be the size of the emerging Insertable Cardiac Monitors (ICM) market in 2026?
Which region is expected to hold the highest market share in the Insertable Cardiac Monitors (ICM) market?
What trends, challenges and barriers will impact the development and sizing of the Global Insertable Cardiac Monitors (ICM) market?
What is sales volume, revenue, and price analysis of top manufacturers of Insertable Cardiac Monitors (ICM) market?
Browse TOC with Selected illustrations and example pages of Insertable Cardiac Monitors (ICM) Market @ https://www.databridgemarketresearch.com/toc/?dbmr=global-insertable-cardiac-monitors-icm-market
Table of Contents: Global Insertable Cardiac Monitors (ICM) Market Research Report
Chapter 1: Insertable Cardiac Monitors (ICM) Market Overview
Chapter 2: Global Economic Impact on Industry
Chapter 3: Global Insertable Cardiac Monitors (ICM) Market Competition by Manufacturers
Chapter 4: Global Production, Revenue (Value) by Region
Chapter 5: Global Supply (Production), Consumption, Export, Import by Regions
Chapter 6: Global Production, Revenue (Value), Price Trend by Type
Chapter 7: Global Market Analysis by Application
Chapter 8: Manufacturing Cost Analysis
Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers
Chapter 10: Marketing Strategy Analysis, Distributors/Traders
Chapter 11: Market Effect Factors Analysis
Chapter 12: Global Insertable Cardiac Monitors (ICM) Market Forecast
Customization of the Report:
Data Bridge Market Research also provides customization options to tailor the reports as per client requirements. This report can be personalized to cater to your research needs. Feel free to get in touch with our sales team, who will ensure that you get a report as per your needs.
Insightful Information Of this Report@ https://www.databridgemarketresearch.com/reports/global-insertable-cardiac-monitors-icm-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
Browse Related Reports@
Intracranial Stents Market
Laparoscopic Electrodes Market
Molecular Cytogenetic Systems Market
#Insertable Cardiac Monitors (ICM) Market Future Trends#Insertable Cardiac Monitors (ICM) Market Analysis#Insertable Cardiac Monitors (ICM) Market Forecast
0 notes
Text
Cardiac Monitoring and Cardiac Rhythm Management Device Market Business Strategies, Future Growth Study, Industry Key Growth Factor Analysis, Deployment Type
Market Research Future has recently declared the expansion of a new research study to its thorough collection of research reports “Worldwide Cardiac Monitoring and Cardiac Rhythm Management Device Market Research Report 2020”.
Cardiac Monitoring and Cardiac Rhythm Management Device Market Analysis
A cardiac monitoring device enables the observing of a patient’s cardiac activity. A cardiac rhythm management device maintains a normal cardiac rhythm in patients suffering from irregular heart rate and rhythm disorder. According to the analysis conducted and the latest report published by MRFR, the global cardiac monitoring and cardiac rhythm management device market are estimated to record a 4% CAGR during the forecast period. Many factors are leading the global market for cardiac monitoring and cardiac rhythm management devices through the review period.
Read more news on: https://www.medgadget.com/2019/12/cardiac-monitoring-and-cardiac-rhythm-management-device-market-2019-global-size-share-emerging-trends-company-profiles-with-growth-factors-by-forecast-2023.html
Some of these factors include the increasing cardiac disorders, changing lifestyles, as well as, technological advancements in cardiac devices. Further, the rising awareness towards cardiac disorders and healthcare programs is contributing heavily to the unparalleled growth witnessed by the global cardiac monitoring and cardiac rhythm management device market. The increasing unmet medical needs in developing and underdeveloped economies have also led to the proliferating adoption of cardiac monitoring and cardiac rhythm management devices in different healthcare organizations and hospitals. The development of new MRI-labeled devices and the economic development in Asia Pacific are likely to drive the cardiac monitoring and cardiac rhythm management device market to a great extent.
Further, increasing technical advancements observed in the drug-eluting, MRI compatible pacemakers, and Holter monitors are some other factors pushing the cardiac monitoring and cardiac rhythm management device market during the forecast period. Intensifying demand for minimally invasive surgeries is correspondingly witnessed to drive growth in the cardiac monitoring and cardiac rhythm management device market. However, some factors are posing as hindrances in the growth of the global cardiac monitoring and cardiac rhythm management device market. Some of the factors refraining the market from growing include stringent regulatory approval procedures, high cost of cardiac devices, and the lack of reimbursement policies in developing countries.
Cardiac Monitoring and Cardiac Rhythm Management Device Market Segmentation
The global cardiac rhythm management and cardiac monitoring device market has been analyzed for various segments. Such segmentation has been carried out on the basis of type, end-users, and region. On the basis of type, the global cardiac monitoring and cardiac rhythm management device market has been segmented into cardiac devices, types of cardiac monitoring devices, and types of cardiac rhythm management devices. Further, the types of cardiac devices segment is further segmented into pacemaker, implantable cardioverter defibrillator, biventricular pacemaker, loop recorder, and implantable cardiac.
The types of cardiac monitoring devices segment has been further sub-segmented into electrocardiogram (ECG), Holter monitor, implantable loop recorder, event monitor, and cardiac output monitoring devices. The Electrocardiogram segment is further sub-segmented into telelectro-cardiogram, lead ECG test, and wireless ECG.
The segment for cardiac rhythm management devices has been sub-segmented into defibrillators, cardiac resynchronization, therapy devices, and pacemakers. The defibrillators segment is further sub-segmented into implantable defibrillators and external defibrillators. Based on end-users, the global cardiac monitoring and cardiac rhythm management device market is segmented into ambulatory surgeries and hospitals.
Cardiac Monitoring and Cardiac Rhythm Management Device Market Regional Analysis
The global cardiac monitoring and cardiac rhythm management device market has been studied for the regional segments of the Americas, Europe, Asia Pacific, and the Middle East & Africa. North America is likely to govern the global cardiac monitoring and cardiac rhythm management device market during the forecast period. Increasing investments by North America in cardiac devices in the last few years has contributed heavily to the ascension of the market in the region. A rising number of cardiac patients, better healthcare infrastructure, and advanced cardiac monitoring technology are also estimated to drive the market to a great extent.
Asia Pacific is expected to garner fastest market growth during the assessment period due to the swelling prevalence of cardiac diseases, mounting investments in healthcare, increasing geriatric population, and the expansion of market players in the region. Asia Pacific is likely to create new growth avenues for cardiac monitoring and cardiac rhythm management device market owing to the production of cost-effective products that are highly demanded in local and global markets.
Cardiac Monitoring and Cardiac Rhythm Management Device Market Key Players
Some of the prominent players in the cardiac monitoring and cardiac rhythm management device market include Abiomed, Brotionik SE and Co. KG, Berlin Hearth, Cardiac Science Corporation, Boston Scientific Corporation, General Electric(GE), Jarvik Hearth. Inc, Koninklijke Philips N.V, Hill Rom Services Inc, LivaNova plc, Nihon Kohden Corporation, ReliantHeart Inc, Medtronic plc, Schiller, and Abbott.
Cardiac Monitoring and Cardiac Rhythm Management Device Industry Update
May 2019: Abbott announced the launch of their latest, smarter heart monitor for better arrhythmia detection. The next-generation Confirm Rx insertable cardiac monitor (ICM) is a paper-sized implantable device that combines smartphone connectivity and can be monitored remotely to track unpredictable hearth rhythm problems.
Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/cardiac-monitoring-advance-technologies-global-market-6332
#Cardiac Monitoring and Cardiac Rhythm Management Device Market#Cardiac Monitoring and Cardiac Rhythm Management Device Market Size#Cardiac Monitoring and Cardiac Rhythm Management Device Market Growth
0 notes
Text
Immunodiagnostics Market is Growing at a CAGR of 15.1% in 2026
immunodiagnostics market is expected to rise from to an estimated value of USD 24.89 billion by 2026 registering a substantial CAGR of 7.80% in the forecast period of 2019-2026. This rise in the market can be attributed to rising prevalence of chronic diseases and technological advancements.
Key Market Competitors: Global Immunodiagnostics Market
Few of the major market competitors currently working in the immunodiagnostics market are Abbott., F. Hoffmann-La Roche Ltd, Danaher., Adaptive Biotechnologies., QIAGEN, AMARANTUS BIOSCIENCE HOLDINGS, INC., AESKU.GROUP GmbH & Co. KG, Avant Diagnostics, Inc., bioMérieux SA, Inova Diagnostics, Inc., OraSure Technologies, Myriad Genetics, Inc, Omega Diagnostics Group PLC, Nexus-Dx, Protagen, Quest Diagnostics Incorporated., Seramun Diagnostica GmbH., SQI Diagnostics, Tecan Trading AG, Siemens Healthcare GmbH, DiaSorin, Erba Diagnostics, Svar Life Science and Exagen Inc. amongst others.
Get Exclusive Sample Report: @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-immunodiagnostics-market
Immunodiagnostics is a diagnostic method that uses antigen-antibody reactions to measure the presence of molecules in biological fluids. It is used primarily for detecting and diagnosing infectious diseases, chronic diseases (cancer, cardiovascular diseases), autoimmune disease, hormonal disorder etc. These tests are also used to distinguish between compatible blood types. They provide precise, quick and accurate results and hence are gaining importance.
Competitive Analysis: Global Immunodiagnostics Market
Global immunodiagnostics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of immunodiagnostics market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Segmentation: Global Immunodiagnostics Market
· By Product (Reagents, Instruments, Software & Services)
· By Technology (ELISA, CLIA, RIA, FIA, Rapid Test, Others)
· By End User (Clinical Laboratories, Hospitals, Academic & Research Centers, Pharmaceutical & Biotechnology Industry, Diagnostic Centers, Others)
· By Application (Oncology & Endocrinology, Hepatitis & Retrovirus Testing, Infectious Disease Testing, GI Stool Testing, Autoimmune Disorders, Bone & Mineral Diseases, Cardiac Biomarkers, Others)
· By Type (Immunodiagnostic Instruments, Immunoassays)
· By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)
Speak to Author @ https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-immunodiagnostics-market
Market Drivers
· Growing ageing & geriatric population would also boost the growth of this market as they are more prone to chronic and infectious diseases
· Rising need for correct, error free and speedy diagnostic tests
· Growing awareness regarding the benefits of immunodiagnostics drives the growth of this market
· Rising adoption of point of care testing (POCT) drives the demand for this market
· Rising volumes of test due to the integration of laboratories would boost the growth of this market
Market Restraints
· Stringent regulations imposed by the government hinder the growth of this market
· Cost of immunodiagnostics being expensive restrains its growth
Reasons to Purchase this Report
· Current and future of global immunodiagnostics market outlook in the developed and emerging markets
· The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
· Regions/Countries that are expected to witness the fastest growth rates during the forecast period
· The latest developments, market shares, and strategies that are employed by the major market players
Customization of the Report:
· All segmentation provided above in this report is represented at country level
· All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)
Acess Full Report: https://www.databridgemarketresearch.com/reports/global-immunodiagnostics-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
Related Reports:
Global Insertable Cardiac Monitors (ICM) Market
Global Cerebral Palsy Market
#Immunodiagnostics Market#Immunodiagnostics#Immunodiagnostics Market Trends#Immunodiagnostics Market Industry#Immunodiagnostics Market News#Immunodiagnostics Market Research
0 notes
Text
Global Immunodiagnostics Market is Projected to Register a Healthy CAGR of 7.80% in the Forecast to 2026
Global immunodiagnostics market is expected to rise from to an estimated value of USD 24.89 billion by 2026 registering a substantial CAGR of 7.80% in the forecast period of 2019-2026. This rise in the market can be attributed to rising prevalence of chronic diseases and technological advancements.
Key Market Competitors: Global Immunodiagnostics Market
Few of the major market competitors currently working in the immunodiagnostics market are Abbott., F. Hoffmann-La Roche Ltd, Danaher., Adaptive Biotechnologies., QIAGEN, AMARANTUS BIOSCIENCE HOLDINGS, INC., AESKU.GROUP GmbH & Co. KG, Avant Diagnostics, Inc., bioMérieux SA, Inova Diagnostics, Inc., OraSure Technologies, Myriad Genetics, Inc, Omega Diagnostics Group PLC, Nexus-Dx, Protagen, Quest Diagnostics Incorporated., Seramun Diagnostica GmbH., SQI Diagnostics, Tecan Trading AG, Siemens Healthcare GmbH, DiaSorin, Erba Diagnostics, Svar Life Science and Exagen Inc. amongst others.
Get Exclusive Sample Report: @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-immunodiagnostics-market
Immunodiagnostics is a diagnostic method that uses antigen-antibody reactions to measure the presence of molecules in biological fluids. It is used primarily for detecting and diagnosing infectious diseases, chronic diseases (cancer, cardiovascular diseases), autoimmune disease, hormonal disorder etc. These tests are also used to distinguish between compatible blood types. They provide precise, quick and accurate results and hence are gaining importance.
Competitive Analysis: Global Immunodiagnostics Market
Global immunodiagnostics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of immunodiagnostics market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Segmentation: Global Immunodiagnostics Market
· By Product (Reagents, Instruments, Software & Services)
· By Technology (ELISA, CLIA, RIA, FIA, Rapid Test, Others)
· By End User (Clinical Laboratories, Hospitals, Academic & Research Centers, Pharmaceutical & Biotechnology Industry, Diagnostic Centers, Others)
· By Application (Oncology & Endocrinology, Hepatitis & Retrovirus Testing, Infectious Disease Testing, GI Stool Testing, Autoimmune Disorders, Bone & Mineral Diseases, Cardiac Biomarkers, Others)
· By Type (Immunodiagnostic Instruments, Immunoassays)
· By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)
Speak to Author @ https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-immunodiagnostics-market
Market Drivers
· Growing ageing & geriatric population would also boost the growth of this market as they are more prone to chronic and infectious diseases
· Rising need for correct, error free and speedy diagnostic tests
· Growing awareness regarding the benefits of immunodiagnostics drives the growth of this market
· Rising adoption of point of care testing (POCT) drives the demand for this market
· Rising volumes of test due to the integration of laboratories would boost the growth of this market
Market Restraints
· Stringent regulations imposed by the government hinder the growth of this market
· Cost of immunodiagnostics being expensive restrains its growth
Reasons to Purchase this Report
· Current and future of global immunodiagnostics market outlook in the developed and emerging markets
· The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
· Regions/Countries that are expected to witness the fastest growth rates during the forecast period
· The latest developments, market shares, and strategies that are employed by the major market players
Customization of the Report:
· All segmentation provided above in this report is represented at country level
· All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)
Acess Full Report: https://www.databridgemarketresearch.com/reports/global-immunodiagnostics-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
Related Reports:
Global Insertable Cardiac Monitors (ICM) Market
Global Cerebral Palsy Market
#Immunodiagnostics Market#Immunodiagnostics#Immunodiagnostics Market Trends#Immunodiagnostics Market Industry#immunodiagnostics market news#Immunodiagnostics Market Research#Immunodiagnostics Market Share
0 notes
Text
Global Immunodiagnostics Market is Growing at a CAGR of 7.80% in 2026
Global immunodiagnostics market is expected to rise from to an estimated value of USD 24.89 billion by 2026 registering a substantial CAGR of 7.80% in the forecast period of 2019-2026. This rise in the market can be attributed to rising prevalence of chronic diseases and technological advancements.
Immunodiagnostics is a diagnostic method that uses antigen-antibody reactions to measure the presence of molecules in biological fluids. It is used primarily for detecting and diagnosing infectious diseases, chronic diseases (cancer, cardiovascular diseases), autoimmune disease, hormonal disorder etc. These tests are also used to distinguish between compatible blood types. They provide precise, quick and accurate results and hence are gaining importance.
Get Exclusive Sample Report: @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-immunodiagnostics-market
Competitive Analysis: Global Immunodiagnostics Market
Global immunodiagnostics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of immunodiagnostics market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Key Market Competitors: Global Immunodiagnostics Market
Few of the major market competitors currently working in the immunodiagnostics market are Abbott., F. Hoffmann-La Roche Ltd, Danaher., Adaptive Biotechnologies., QIAGEN, AMARANTUS BIOSCIENCE HOLDINGS, INC., AESKU.GROUP GmbH & Co. KG, Avant Diagnostics, Inc., bioMérieux SA, Inova Diagnostics, Inc., OraSure Technologies, Myriad Genetics, Inc, Omega Diagnostics Group PLC, Nexus-Dx, Protagen, Quest Diagnostics Incorporated., Seramun Diagnostica GmbH., SQI Diagnostics, Tecan Trading AG, Siemens Healthcare GmbH, DiaSorin, Erba Diagnostics, Svar Life Science and Exagen Inc. amongst others.
Segmentation: Global Immunodiagnostics Market
· By Product (Reagents, Instruments, Software & Services)
· By Technology (ELISA, CLIA, RIA, FIA, Rapid Test, Others)
· By End User (Clinical Laboratories, Hospitals, Academic & Research Centers, Pharmaceutical & Biotechnology Industry, Diagnostic Centers, Others)
· By Application (Oncology & Endocrinology, Hepatitis & Retrovirus Testing, Infectious Disease Testing, GI Stool Testing, Autoimmune Disorders, Bone & Mineral Diseases, Cardiac Biomarkers, Others)
· By Type (Immunodiagnostic Instruments, Immunoassays)
· By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)
Speak to Author @ https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-immunodiagnostics-market
Market Drivers
· Growing ageing & geriatric population would also boost the growth of this market as they are more prone to chronic and infectious diseases
· Rising need for correct, error free and speedy diagnostic tests
· Growing awareness regarding the benefits of immunodiagnostics drives the growth of this market
· Rising adoption of point of care testing (POCT) drives the demand for this market
· Rising volumes of test due to the integration of laboratories would boost the growth of this market
Market Restraints
· Stringent regulations imposed by the government hinder the growth of this market
· Cost of immunodiagnostics being expensive restrains its growth
Reasons to Purchase this Report
· Current and future of global immunodiagnostics market outlook in the developed and emerging markets
· The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
· Regions/Countries that are expected to witness the fastest growth rates during the forecast period
· The latest developments, market shares, and strategies that are employed by the major market players
Customization of the Report:
· All segmentation provided above in this report is represented at country level
· All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)
Acess Full Report: https://www.databridgemarketresearch.com/reports/global-immunodiagnostics-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
Related Reports:
Global Insertable Cardiac Monitors (ICM) Market
Global Cerebral Palsy Market
#immunodiagnostics market#immunodiagnostics#immunodiagnostics market Trends#immunodiagnostics market Industry#immunodiagnostics market News
0 notes
Text
A comprehensive study of Cardiac Implant Devices Market
Introduction: By the end of 2024, the global market size for cardiac implant devices market is projected to grow with a CAGR of 4.30 percent to reach USD40.300 billion from USD31.300 billion in 2018. Cardiovascular implants are sophisticated devices used to treat heart diseases. Cardiac diseases are a major cause of death globally. But due to technological advancement in medical science, there is an increasing number of patients living with cardiovascular diseases. The market for cardiac implant devices is expected to have a significant growth rate driven by the rising prevalence of heart diseases and growing healthcare expenditure. The growth in the geriatric population is expected to further fuel the market growth as cardiac diseases are mostly age-associated. Technological advancement in the field of medical devices is also expected to drive the cardiac implant devices market growth.
Rising prevalence of heart diseases:
According to data by the World Health Organisation, 17.9 million people die each year from cardiovascular diseases (CVD), an estimated 31% of all deaths worldwide. Four out of five CVD deaths are due to heart attacks and strokes. A substantial number of these deaths can be attributed to tobacco smoking, which increases the risk of dying from coronary heart disease and cerebrovascular disease 2–3 fold. Physical inactivity and unhealthy diet are other main risk factors which increase individual risks to cardiovascular diseases. Implantable medical devices are increasingly being used for the treatment of these diseases. Cardiovascular IMDs are regarded as the most sophisticated IMDs to date. As these devices are implanted inside the body, the patients do not need to be hospitalized for long periods of time and can even be remotely monitored. The implementation of more IMDs with communication capabilities relieve the strain on health systems. So, the demand for cardiac implant devices is increasing globally with the rise in patients suffering from heart diseases. This is expected to have a positive impact on cardiac implant devices market size.
Cardiac implant devices market by product type:
By product type, the cardiac implant devices market is segmented as Implantable Closure Devices, Pacemaker Implants, Implantable Cardioverter Defibrillator (ICD), Left Atrial Appendage (LAA) Closure Device, Coronary Stents, and Prosthetic Heart Valves, Insertable Cardiac Monitor (ICM), Implantable Heart Pump, and Total Artificial Heart. The coronary stents segment is expected to hold a significant CAGR during the forecast period on account of the growing prevalence of coronary heart diseases worldwide. Implantable heart pump is expected to hold a significant cardiac implant devices market share.
Implantable Heart Pump:
A heart pump or ventricular assist device (VAD) is a mechanical pump that's used to support heart function and blood flow in people who are suffering from heart diseases. The device takes blood from a lower chamber of the heart and helps pump it to the body and vital organs, which is same as the working of a healthy heart. These devices can be connected externally or implanted inside the body. Implantable heart pump is used in patients who have heart failure. The cardiac implant devices market trend for this segment is expected to be positive in the forecast period due to increasing cases of heart failures and the growing geriatric population.
0 notes
Text
Cardiac Monitoring Devices Market Analysis By Geography, Competitors, Trends and Demands To 2026
Cardiac monitoring devices enable continual observation of patients with heart disorders. These devices are commonly used in emergency rooms and critical care units and primarily in arrhythmias to monitor the rate of heartbeats. Common types of cardiac monitoring devices include holter monitors, event monitors, loop monitors, and insertable cardiac monitors. The additional parameters monitored noninvasively by cardiac monitors include blood pressure, cardiac output, intravascular pressures, arterial blood oxygen saturation, and blood temperature.
Rise in incidence of cardiovascular diseases such as cardiac arrthymia, ischemic heart disease, and hypertension is expected to fuel growth of the cardiac monitoring devices market. According to World Health Organization (WHO), 2015, cardiovascular diseases was the leading cause of deaths accounting for 17.7 million deaths, globally. Furthermore, increasing applications of cardiac monitors in continuous monitoring for patients with severe electrolyte imbalances and for postoperative observation is expected to augment the market growth over the forecast period.
Development of technologically advanced cardiac monitoring devices is expected to boost the cardiac monitoring devices market growth over the forecast period
Development of advance cardiac monitoring devices such as remote cardiac monitoring devices and wireless cardiac monitoring devices providing early detection is a major factor expected to boast the cardiac monitoring devices market growth over the forecast period. For instance, ZywiePro, the next-generation cardiac remote monitoring solution launched in 2015, leverages mobile and cloud technology to facilitate detection of cardiovascular arrhythmias. ZywiePro enables physicians to provide more personalized and effective patient care by detailed diagnostic insight into the cardiovascular health of the patients. However, factors inhibiting the cardiac monitoring devices market include high cost of device and lack of knowledge about advance cardiac monitoring devices.
Advance cardiac monitoring devices enable physician to make accurate diagnosis and determine a treatment plan. For instance, the Reveal LINQ Insertable Cardiac Monitor manufactured by Medtronic, approved by FDA in 2014, is currently the smallest heart monitor in the market. It can diagnose the cause of infrequent, unexplained fainting spells better than conventional testing.
Market Taxonomy:
The global cardiac monitoring devices market is segmented on the basis of product type, application, end user, and geography.
On the basis of product type, the cardiac monitoring devices market in segmented into:
Holter Monitor
Event Monitor
Loop Monitor
Insertable Cardiac Monitor (ICM)
Mobile Cardiac Telemetry Devices
On the basis of application, the cardiac monitoring devices market in segmented into:
Arrhythmia
Coronary Artery disease
Hypertension
Ischemic Heart Disease
On the basis of end user, the cardiac monitoring devices market in segmented into:
Hospital
Diagnostic Centers
Ambulatory Surgical Centers
North America is expected to dominate the cardiac monitoring devices market over the forecast period, owing to increasing prevalence of cardiovascular diseases in the region
Regional segmentation of cardiac monitoring devices market by Coherent Market Insights comprises North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in global cardiac monitoring devices market over the forecast period, due to increasing prevalence of cardiovascular diseases in the region. According to the American Heart Association (AHA), 2017, about 92.1 million adults in the U.S. are suffering from some form of cardiovascular disease or the after-effects of stroke. AHA also stated in its report, that direct and indirect costs of cardiovascular diseases and stroke are estimated to account for US$ 316 billion, including health expenditures and lost productivity. Growth in Europe market is driven by emergence of innovative cardiac solutions offered by regional manufacturers and rising cases of cardiovascular diseases. For instance, LifeWatch —manufacturer of two innovative Mobile Cardiac Telemetry (MCT) solutions — LifeWatch MCT 3 Lead and LifeWatch MCT 1 Lead Patch detects, records, and wirelessly transmits asymptomatic and symptomatic arrhythmia to clinicians for analysis. According to European Heart Network and European Society of Cardiology 2015, over 85 million people suffer from cardiovascular disease (CVD) every year, causing over 4 million deaths in Europe.
Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/1272
Asia Pacific is also expected to witness high growth. This is attributed to availability of technological advanced products and rising healthcare concern for stroke prevention associated with atrial fibrillation. According to the Japanese Heart Rhythm Society in 2017, the Asian population with atrial fibrillation (AF) is estimated to reach 72 million by 2050, of whom 2.9 million may suffer from AF-associated strokes.
Increasing FDA clearance for new and innovative products is a major factor fueling cardiac monitoring devices market growth
In 2016, the FDA approved wireless continuous non-invasive 'Beat-by-Beat' blood pressure and heart rate monitor manufactured by CareTaker Medical based on patented finger cuff technology. The device allows physicians to remotely monitor medical-grade continuous blood pressure and heart rate from anywhere, using only a patient friendly-finger cuff. Key players in cardiac monitoring devices market are Philips Healthcare, Medtronic, Boston Scientific, Cardiac Science, LifeWatch, CareTaker Medical, Spacelabs, St. Jude Medical, Kohden, CardioNet, and Mortara Instrument.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
0 notes
Text
Implantable Cardiac Pacemaker Market - Global Forecast to 2026
Implantable cardiac pacemaker is a small device implanted in the chest or abdomen for the treatment of abnormal heart rhythms, arrhythmia, heart block, and atrial fibrillation. Implantable cardiac pacemaker is evolved from battery-powered transistorized wearable pacemakers to current leadless pacemaker, an entire pacemaker which is placed within cardiac chambers. Cardiac pacemakers are used to treat abnormal electrical signaling in the heart, which causes arrhythmias. Implantable cardiac pacemaker use low-energy electrical signals to speed up the slow heartbeat, help to control an abnormal and fast heart rhythm, and prevents long QT syndrome, a disorder of the heart’s electrical activity, which causes sudden, uncontrollable, and dangerous arrhythmias.
Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1663
Market Dynamics
Market players are engaged in developing novel pacemakers with ability to control the abnormal heart rhythm, monitor and record patient’s heart's electrical activity, blood temperature, and breathing rate. Technological advances in the field of implantable cardiac pacemakers along with increasing prevalence of cardiovascular disease is projected to drive the growth of implantable cardiac pacemaker market over the forecast period.
Introduction of Advanced Pacemaker Technologies is Expected to Drive Growth of the Implantable Cardiac Pacemaker Market
Adoption of advanced technologies in cardiac pacemakers such as MRI safe-pacemakers, pacemakers with improved battery life, delay the progression of persistent Atrial Fibrillation (AF) in patients suffering from bradycardia and wireless automated technologies. This advancements are gaining significant traction of various market players of implantable cardiac pacemakers with affordable costs, which in turn are expected to drive growth of implantable cardiac pacemakers market. For instance, in February 2017, Abbott received the Food and Drug Administration (FDA) approval for its MR-conditional labeling for both of its products i.e. Assurity MRI pacemaker and the Tendril MRI pacing lead. Furthermore, introduction of advance technology such as wireless and automated pacemaker monitoring pacemakers are gaining significant traction among healthcare providers.
For instance, in 2016, Biotronik launched CardioMessenger Smart, portable monitoring device in the U.S. This system is about the size of a modern smartphone used to keep pacemaker, Implantable Cardioverter Defibrillator (ICD) and Insertable Cardiac Monitor (ICM) patients connected to their physician remotely. This CardioMessenger Smart helps to ensure patient compliance and the consistent transmission of data necessary for physicians to identify and prevent potential cardiac events. Thus, such wireless technologies are gaining traction of vendors, which is expected to drive the growth of the implantable cardiac pacemaker market
Increasing Prevalence of Cardiovascular Disease is Expected to Drive Growth of Implantable Cardiac Pacemaker Market
Increasing incidence of cardiovascular diseases is expected to boost growth of the implantable cardiac pacemakers market over the forecast period. According to the Centers for Disease Control and Prevention (CDC), August 2017 data findings, Atrial Fibrillation (AFib or AF) is most common type of heart arrhythmia, which affected an estimated 2.7 to 6.1 million people in the U.S. and the number is expected to increase in near future. Furthermore, Atrial Fibrillation cases increase with age and it is more prominent in men than women. Moreover, increasing number of geriatric population across the various regions worldwide along with high prevalence of heart disease is expected to propel demand for implantable cardiac pacemakers in the near future.
However, implantable pacemakers associated infections in cardiac patients is hindering growth of the implantable cardiac pacemaker market. Pacemaker surgery is associated with swelling, bruising, bleeding, or infection of the area where the pacemaker was placed leading to blood vessel or nerve damage and adverse reaction of medicine used during the pacemaker implantation surgery, which may reduce the adoption of implantable cardiac implants in patients.
For More Information @ https://www.coherentmarketinsights.com/market-insight/implantable-cardiac-pacemaker-market-1663
Global Key Players:
Some of the key players operating in implantable cardiac pacemaker market include Medtronic plc, BIOTRONIK, Inc., Boston Scientific Corporation, St. Jude Medical, Vitatron Holding B.V., Shree Pacetronix Ltd., MEDICO S.p.A., Lepu Medical Technology Co Ltd., LivaNova PLC, and Qinming Medical.
Detailed Segmentation:
Global Implantable Cardiac Pacemaker Market, By Product Type:
Single Chamber Pacemaker
Dual Chamber Pacemaker
Biventricular Pacemaker
Global Implantable Cardiac Pacemaker Market, By Application:
Heart Block
Arrhythmia
Atrial fibrillation
Long QT Syndrome
Bradycardia
Tachycardia
Others
Global Implantable Cardiac Pacemaker Market, By End User:
Hospitals
Emergency Care Centers
Others
Global Implantable Cardiac Pacemaker Market, By Region:
North America
Europe
Asia Pacific
Middle East
Latin America
Africa
Request For Customization @ https://www.coherentmarketinsights.com/insight/request-customization/1663
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
0 notes
Text
Cardiac Holter Monitor Market Trends Assessment by 2025
Cardiac Holter Monitor is a portable battery operated device that records and measures a person’s heart activity (ECG) continuously at a stretch for 24 hours to 48 hours or even for a longer period depending on the type of monitoring used. The device has wires with silver dollar-sized electrodes that attach to the skin of a person.
Demand Scenario
The global cardiac holter monitor market was USD 352.55 million in 2018 and is estimated to reach USD 549.69 million by 2025 at a CAGR of 6.55% during the forecast period
Request For Report sample @ https://www.trendsmarketresearch.com/report/sample/3946
Growth by Region
North America holds the largest market share owing to the increasing preference of patients towards minimally invasive diagnostic tools and also sufficient funding from government for the treatment of the cardiovascular disorder. Asia-Pacific region, on the other hand, is anticipated to grow rapidly with a very high CAGR in the years to come. While, countries in Latin America, Middle East and Africa face a sluggish growth and are rising their investments to expand their physical presence globally
Drivers vs Constraints
The market is mainly driven by rising stress levels and hectic lifestyle in people globally resulting in cardiac blockage and arrest. For instance, the American Heart Association in the US is focusing mainly on bringing down the upsurge of deaths and incidences of stroke by 20 percent caused by cardiovascular devices. This has resulted in the upsurge of demand for advanced technology devices for analysis and diagnosis. Nonetheless, the global cardiac holter monitor market is curbed by growing healthcare awareness along with a prominent need to reduce the cardiac disorder globally in the near future.
Request For Report Discounts @ https://www.trendsmarketresearch.com/report/discount/3946
Industry Trends and Updates
Spacelabs Healthcare, a global manufacturer of medical equipment has invested USD 720,000 into Nursing Laboratory at University of Massachusetts Amherst which will benefit students who study Bachelor of Science in Nursing program since they are the frontline of healthcare who uses these tools extensively.
Abbott Laboratories, an American healthcare company has launched the first and only smartphone compatible Insertable Cardiac Monitor (ICM) in the U.S. to help physicians remotely identify cardiac arrhythmias in patients and being able to engage in their healthcare.
More Info of Impact Covid19@ link https://www.trendsmarketresearch.com/report/covid-19-analysis/3946
0 notes
Text
Global Implantable Cardiac Monitors Market
Global Implantable Cardiac Monitors Market was valued US$ 515.1 Mn in 2017 and is expected to reach US$ 2090.4 Mn by 2026, at a CAGR of 19.14 % during forecast period.
Global Implantable Cardiac Monitors Market
Implantable cardiac monitor, also known as implantable loop recorder, is a small insertable device that constantly monitors hearth rhythms. These monitors are considered as the gold standard for estimating the irregular and unexplained arrhythmias.
Major driving factor behind the market growth is the durability of implantable cardiac monitors. Additionally, implanting a cardiac monitor requires less duration, so less hospital stay and fewer hospital readmission are required. On the other hand, availability of alternative mode of treatments and high expenditures of implantable cardiac monitors is limiting the growth of Implantable Cardiac Monitors market. Also, increasing awareness of devices and treatment options for cardiac disorders will create productive opportunities for the key players in this market.
Implantable Cardiac Monitors Market have met significant development over the recent years and is expected to grow massively during forecast period. Implantable cardiac monitors (ICM) are tiny electrophysiology devices which are used for monitoring a patient's heart movement for a long period of time. These additionally helping in recognizing arrhythmias. Technology of implantable cardiac monitor can wipe out the necessity for mass outer Holter screen, which needs wire to be connected to a patient. ICM is a framework which is used to monitor heart failure and that prevents hospitalization of patients. ICMs are inserted under the skin of the patient. These monitors help doctors to estimate the health of patient's by making use of cardiac rhythm. Additionally, these are used for monitoring many cardiovascular issues, for example, atrial fibrillation, heart failure, and signs of recent heart attack.
Two main equipment’s used for cardiac arrhythmias are Electrocardiogram (ECG) and Holter monitor. Usage of ECG monitoring devices and services are increasing rapidly over the past decade. ECG have penetrated into various departments due to its wide use in mobile cardiac outpatient telemetry and currently in data management for electronic medical records (EMR). Growing number of life threatening cardiac diseases are resulting into increase in the demand for ECG monitoring devices and services in hospitals and diagnostics laboratories with the essential and advanced software services. Above-mentioned factors will increase the demand for ECG monitoring devices, data management and services in large integrated healthcare systems.
Atrial Fibrillation cases within the elderly population, preference for catheter ablation, and escalating technological developments are boosting the AF market growth. Atrial fibrillation is a majorly common arrhythmia which results in disturbed cardiac rhythms. In the last twenty years, a higher presence of AF incidences have been witnessed around the globe. The ‘American Heart Association’ stated that about 34 million people were afflicted with AF globally in 2013.
Global Implantable Cardiac Monitors
North America dominates the global implantable cardiac monitor market, due to the high adoption rate of technologically advanced implantable cardiac monitors, presence of highly sophisticated healthcare infrastructure and favorable reimbursement framework, and presence of major players in North America. Implantable cardiac monitors are niche, and this provides major opportunities for companies to enlarge and invest in the region. Similarly, rise in the prevalence of cardiovascular conditions that requires advance monitoring contributes to the demand for implantable cardiac monitors.
The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Implantable Cardiac Monitors Market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, report also focuses on competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, SWOT analysis to address questions of shareholders to prioritizing the efforts and investment in near future to emerging segment in Implantable Cardiac Monitors Market.
Scope of Global Implantable Cardiac Monitors Market:
Global Implantable Cardiac Monitors Market by Indication:
• Cardiac Arrhythmias
• Atrial Fibrillation
• Epilepsy & Unexplained Falls
Global Implantable Cardiac Monitors Market by End User:
• Hospitals
• Cardiac Center & Clinics
• Ambulatory Surgical Centers (ASCs)
Global Implantable Cardiac Monitors Market by Geography:
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East & Africa
Key Players Operating in the Market Includes:
• Abbott Laboratories
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Edwards Lifescience Corporation
• General Electric Company
• Koninklijke Philips N.V.
• LivaNova PLC
• Medtronic plc
• Nihon Kohden Corporation
• Phoenix Heart Center
• Astellas Pharma, Inc.
• Sigma-Aldrich Corporation
• Agilent Technologies, Inc.
• ReliantHeart Inc.
• Abiomed, Inc.
• Basilea Pharmaceutical Ltd.
• Berlin Heart GmbH
• Schiller AG
• Jarvik Heart, Inc
This Report Is Submitted By Maximize Market Research
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
Contact info:
Name: Lumawant Godage
Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.
Email: [email protected]
Address: Maharashtra 411051, India.
0 notes
Text
Remote cardiac monitoring services Market Size, Share, Huge Growth And Forecasts Report 2019 To 2026
The recent report, Remote Cardiac Monitoring Services Market fundamentally discovers insights that enable stakeholders, business owners and field marketing executives to make effective investment decisions driven by facts – rather than guesswork. The study aims at listening, analyzing and delivering actionable data on the competitive landscape to meet the unique requirements of the companies and individuals operating in the Remote Cardiac Monitoring Services Market for the forecast period, 2019 to 2026. To enable firms to understand the Remote cardiac monitoring services industry in various ways the report thoroughly assesses the share, size and growth rate of the business worldwide.
Request for FREE Sample Copy of Remote Cardiac Monitoring Services Market Report @ https://www.reportsanddata.com/sample-enquiry-form/1444
Various research techniques are applied to produce data on competitors’ strategies; past, present and future sales and purchasing trends. Business owners planning on surveying the present customers and reaching the target audience will benefit from the demographic data from different regions, to infer dynamic market shifts. Perspectives on different disruptive forces that are believed to have a transformative influence on the future sales make the document valuable. Insights on where the Remote cardiac monitoring services Market should be heading during the forecast period, 2019 to 2026 and how major vendors are transforming the business today are also explored when drafting the report.
The study explores what the future Remote Cardiac Monitoring Services Market will look like. Most importantly, the research familiarizes product owners with whom the immediate competitors are and what buyers expect and what are the effective business strategies adopted by prominent leaders. To help both established companies and new entrants not only see the disruption but also see opportunities. In-depth exploration of how the industry behaves, including assessment of government bodies, financial organization and other regulatory bodies. Beginning with a macroeconomic outlook, the study drills deep into the sub-categories of the industry and evaluation of the trends influencing the business.
In market segmentation by manufacturers, the report covers the following companies- Preventice Solutions, Honeywell Life Care Solutions, Cardionet, Koninklijke Philips, Medtronic, Boston Scientific Corporation, Biotronik SE & Co. KG, Cardiac Science Corporation, Hill-Rom Holdings, Inc., LivaNova PLC, ReliantHeart Inc., St. Jude Medical, Inc, and Schiller AG.
Segments covered in the report: For the purpose of this report, according to Product type, Technology, Event monitoring, Application and End-user:
Product Type Outlook (Revenue, USD Billion; 2016-2026) • Cardiac Event Recorder • Loop memory Monitor • Symptom event monitor • Holter Monitor • Insertable Cardiac Monitor (ICM) • Mobile Cardiac Telemetry Devices
Technology Type Outlook (Revenue, USD Billion; 2016-2026) • Digital Health Technology • Mobile Cardiac Telemetry Monitoring (MCT/MCOT) • Artificial Intelligence • AutoDetect Monitors • Manual Event Monitor • Smart Wearable ECG Monitors
Buy Now: https://www.reportsanddata.com/checkout-form/1444
Event monitoring Type Outlook (Revenue, USD Billion; 2016-2026) • Pre-Symptom (Memory Loop) • Post-Symptom Event Monitor
Application Type Outlook (Revenue, USD Billion; 2016-2026) • Coronary Artery Disease • Arrhythmia • Hypertension
End-user Outlook (Revenue, USD Billion; 2016-2026) • Diagnostic Centers • Hospitals • Ambulatory Surgical Centers • Academic and Research Institutions • R&D Centers
The research provides answers to the following key questions : • What will be the marketing and pricing strategies followed by the prominent vendors operating in the Remote Cardiac Monitoring Services Market for the forecast period, 2019 to 2026? • What are new uses for the existing products or services and how have they contributed in increasing the demand for products or services? • What are the general conditions prevailing and influencing the business environment of the Remote Cardiac Monitoring Services Market? • Who are the major manufacturers exploring new regions for their products and services? • What will be the status of demand and supply and distribution channel requirements worldwide in the coming years? • What will be the market share of the Remote Cardiac Monitoring Services Market over the various time periods?
To Read More: https://www.reportsanddata.com/report-detail/remote-cardiac-monitoring-services-market
About Us: Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.
Contact Us: John Watson Head of Business Development Direct Line: +1-212-710-1370 E-mail: [email protected] Reports and Data | Web: www.reportsanddata.com News: www.reportsanddata.com/market-news
0 notes
Text
Implantable Cardiac Monitor Market is Anticipated to Reach US$ 1,464.26 Mn by 2026
Transparency Market Research (TMR) has published a new report titled ‘Implantable Cardiac Monitor Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ According to the report, the global implantable cardiac monitor market was valued at US$ 679.24 Mn in 2017. The market is anticipated to reach US$ 1,464.26 Mn by 2026, expanding at a CAGR of 8.7% during the forecast period. Rise in the incidence of cardiac arrhythmia and increase in geriatric population are expected to augment the global market from 2018 to 2026. The global implantable cardiac monitor market is projected to expand, owing to prolonged ECG monitoring function, acceptance of and rise in demand for subcutaneous insertible cardiac devices, and increase in technological advancements.
Rise in Prevalence of Cardiac Arrhythmia is Propelling the Global Cardiac Monitor Market
The global implantable cardiac monitor market is expanding at a high growth rate, driven by an increase in prevalence of cardiac arrhythmia. As per research, about 14 million people are suffering from some forms of cardiac arrhythmia in the U.S. with more than 4 million Americans have recurrent arrhythmia and 5 million Americans are currently living with heart conditions. In Asia Pacific, Japan is expected to reach 1 million cardiac arrhythmia patients in the coming years.
Request a PDF Sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=50316
Increase in the Global Geriatric Population is Driving the Need for Effective Treatment, Globally
Prevalence of cardiovascular diseases such as heart stroke and improper function of the heart are driving the need for cardiac monitoring devices in order to monitor irregular heart rhythms. Elderly people are often prone to cardiac arrhythmia, especially atrial fibrillation, which occurs in old age, resulting in need for cardiac monitors. External cardiac monitors are not feasible for old people to wear or carry on a day to day basis. This has led to an increase in the adoption of insertable cardiac monitors. Implantable cardiac monitor devices offer better ECG monitoring service and also last for three years. Rise in the geriatric population demands better treatment options, which in turn, is likely to provide opportunities for companies operating in the global implantable cardiac monitor market.
North America Dominates the Global Implantable Cardiac Market Owing to Rise in Demand for Implantable Cardiac Monitors
North America dominates the global implantable cardiac monitor market, owing to the approval of cardiac monitors and the presence of major players in this region. Implantable cardiac monitors are niche, and this offers significant opportunities for companies to expand and invest in the region. Also, a rise in the prevalence of cardiovascular conditions that need further monitoring contributes to the demand for implantable cardiac monitors. Rise in atrial fibrillation, a type of cardiac arrhythmia, and other arrhythmias drives the market in the region.
Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=50316
A subcutaneous cardiac monitor is a new innovation that is gaining trust and popularity among the geriatric population, owing to its prolonged ECG monitoring benefits. Therefore, easy adoption of ICM is fuelling the market in the region.
First and only Smartphone Compatibility Implantable Medical Device for Cardiac Monitoring and Rise in Investments in Research & Development Offer Significant Opportunities to New Entrants
Key market players have invested in establishing a better way for the treatment of patients by providing innovate ways of monitoring irregular heart rhythms on smartphones. This innovation allows physicians to directly access data and keep track of patients’ condition.
Also, companies are readily investing in this type of technology. They also hold a strong portfolio of products in the pipeline that are ready to enter the market. Due to the presence of few players in the global market, other companies have a significant opportunity to enter the market with innovative solutions.
Investments and Mergers & Acquisitions by Key Players are Driving the Implantable Cardiac Monitor Market
Key players dominating the global implantable cardiac monitor markets are Medtronic, Abbott, Biotronik, Angel Medical Systems, Inc., vectoriousmedtech.com, Boston Scientific Corporation or its affiliates, and Biosense Webster, Inc.. Major players are focusing on mergers and acquisitions and are incorporating innovative technologies to expand their footprint in the global implantable cardiac monitor market.
About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Contact us:
Transparency Market Research 90 State Street, Suite 700, Albany NY – 12207 United States Tel: +1-518-618-1030 USA – Canada Toll Free 866-552-3453 Email: [email protected] Website: http://www.transparencymarketresearch.com/
0 notes